PDGFRA and glioblastoma: These alterations further select for mutations in familiar cancer-related genes, such as TERT (promoter region), NF1, TP53, PDGFRA, CDK4, and EGFR, which occur at a high frequency among GBM patients and are considered required events that drive tumorigenesis.